Recruiting
A Registered Cohort Study on Duchenne Muscular Dystrophy
What is being collected
Data Collection
Collected from today forward - ProspectiveWho is being recruted
Muscular Diseases+7
+ Muscular Dystrophies
+ Musculoskeletal Diseases
Over 2 Years
+4 Eligibility Criteria
How is the trial designed
Cohort
Tracking disease incidence in order to identify risk factors and understand disease progression over time.Observational
Study Start: July 2019
Summary
Principal SponsorNing Wang, MD., PhD.
Study ContactNing Wang, MD, PhDMore contacts
Last updated: January 28, 2026Sourced from a government-validated database.Claim as a partner
Study start date: July 1, 2019
Actual date on which the first participant was enrolled.Dystrophinopathy is a term of X-linked recessive genetic disease, including Duchenne Muscular Dystrophy, Becker Muscular Dystrophy, and the X-linked dilated cardiomyopathy. The aim of this study is to determine the clinical spectrum and natural progression of dystrophinopathy in a prospective multicenter natural history study, to assess the clinical, genetic of patients with dystrophinopathy to optimize clinical management.
Official TitleA Registered Cohort Study on Duchenne Muscular Dystrophy
Principal SponsorNing Wang, MD., PhD.
Study ContactNing Wang, MD, PhDMore contacts
Last updated: January 28, 2026Sourced from a government-validated database.Claim as a partner
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.Design Details
2000 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Cohort
These studies follow a group of individuals with common characteristics (such as a condition or birth year) over a specific period to study health outcomes or exposures.
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Conditions
Criteria
Any sex
Biological sex of participants that are eligible to enroll.Over 2 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Muscular DiseasesMuscular DystrophiesMusculoskeletal DiseasesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesNervous System DiseasesNeuromuscular DiseasesMuscular Dystrophy, DuchenneMuscular Disorders, AtrophicGenetic Diseases, InbornGenetic Diseases, X-Linked
Criteria
3 inclusion criteria required to participate
Beyond 2 years old
Diagnosis with Duchenne Muscular Dystrophy, and female carriers, genotypically confirmed
Diagnosis should be supported by muscle biopsy, if no genetic confirmation.
1 exclusion criteria prevent from participating
Presence of other clinically significant illness
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.Study Objectives
Study Objectives
Primary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
Recruiting
First Affiliated Hospital of Fujian Medical University
Fuzhou, ChinaOpen First Affiliated Hospital of Fujian Medical University in Google MapsRecruiting
One Study Center